Lack of Reduction of Left Ventricular Mass in Treated Hypertension: The Strong Heart Study
Open Access
- 20 May 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 2 (3) , e000144
Abstract
Background: Hypertensive left ventricular mass ( LVM ) is expected to decrease during antihypertensive therapy, based on results of clinical trials. Methods and Results: We assessed 4‐year change of echocardiographic LVM in 851 hypertensive free‐living participants of the Strong Heart Study (57% women, 81% treated). Variations of 5% or more of the initial systolic blood pressure ( SBP ) and LVM were categorized for analysis. At baseline, 23% of men and 36% of women exhibited LV hypertrophy ( LVH , P P P P P <0.001) than those whose LVM decreased. After adjusting for field center, initial LVM index, target BP , and kinship degree, lack of decrease in LVM was predicted by higher baseline BMI and urinary albumin/creatinine excretion, independently of classes of antihypertensive medications, and significant effects of older age, male gender, and percentage increase in BP over time. Similar findings were obtained in the subpopulation (n=526) with normal BP at follow‐up. Conclusions: In a free‐living population, higher BMI is associated with less reduction of hypertensive LVH ; lack of reduction of LVM is independent of BP control and of types of antihypertensive treatment, but is associated with renal damage.Keywords
This publication has 44 references indexed in Scilit:
- Impact of overweight and obesity on cardiac benefit of antihypertensive treatmentNutrition, Metabolism and Cardiovascular Diseases, 2013
- Sodium, Left Ventricular Mass, and Arterial HypertensionHypertension, 2011
- Regression of Left Ventricular Mass by Antihypertensive TreatmentHypertension, 2009
- Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart StudyJournal Of Hypertension, 2008
- Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic SyndromeJACC, 2008
- Association of suboptimal blood pressure control with body size and metabolic abnormalitiesJournal Of Hypertension, 2007
- Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)The American Journal of Cardiology, 1996
- Left ventricular mass and exercise responses predict future blood pressure. The Muscatine Study.Hypertension, 1988
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Myocardial fat infiltrationAmerican Heart Journal, 1962